Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00910325 · ClinicalTrials.gov registry record · Phase 1
Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00910325: Clinical Trial Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00910325 is a Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00910325, a Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
To determine the feasibility, safety, and efficacy of a novel minimally invasive approach to cholecystectomy and to establish a description of this novel translumenal technique in humans at this institution.
Interventions
- PROCEDURE Laparoscopic-assisted transvaginal cholecystectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00910325
The ClinicalTrials.gov registry entry for NCT00910325 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laparoscopic-assisted transvaginal cholecystectomy is the first listed.
NCT00910325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00910325 about?
NCT00910325 is a clinical study titled "Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy". To determine the feasibility, safety, and efficacy of a novel minimally invasive approach to cholecystectomy and to establish a description of this novel translumenal technique in humans at this institution.
What is the current status of trial NCT00910325?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00910325?
The interventions under investigation include: Laparoscopic-assisted transvaginal cholecystectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00910325?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.